Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [6111]

Antibody fragment-nanoparticle therapeutic eradicates cancer

Antibody fragment-nanoparticle therapeutic eradicates cancer

How genome doubling helps cancer develop

How genome doubling helps cancer develop

Study offers a potential strategy to improve T cell therapy in solid tumours

Study offers a potential strategy to improve T cell therapy in solid tumours

Study unravels a cause of resistance to novel drug in patients with acute leukaemia

Study unravels a cause of resistance to novel drug in patients with acute leukaemia

Scientists reveal a potential new approach to treating liver cancer

Scientists reveal a potential new approach to treating liver cancer

EAU 2023: Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows

EAU 2023: Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows

EAU 2023: New technique reduces postoperative complications in prostate cancer surgery

EAU 2023: New technique reduces postoperative complications in prostate cancer surgery

Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows

Delaying treatment for localised prostate cancer does not increase mortality risk, trial shows

Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity mediating PD-L1 high CD11b+ cells elimination in HCC

Anti-PD-L1 antibody enhances curative effect of cryoablation via antibody-dependent cell-mediated cytotoxicity...

NMPA conditionally approves gumarontinib for treatment of non-small cell lung cancer with MET Exon 14 skipping mutation

NMPA conditionally approves gumarontinib for treatment of non-small cell lung cancer with MET Exon 14 skipping...

More from ecancer